首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Efficacy and mechanism of action of Yin Lai Tang (lung-stomach treatment) in dyspepsia mouse infected by FM1 virus
【24h】

Efficacy and mechanism of action of Yin Lai Tang (lung-stomach treatment) in dyspepsia mouse infected by FM1 virus

机译:尹莱汤(肺胃治疗)在FM1病毒感染的情况下尹莱汤(肺胃处理)的作用和机制

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to assess the efficacy and elaborate the mechanism of action of Yin Lai Tang (Lung-Stomach Treatment) on dyspepsia mouse infected by FM1 virus. Ninety male, 4 week old Kunming mouse with 12-14 g weight, were randomly divided into 9 groups, i.e., normal, infected, dyspepsia, ribavirin, Shuanghuanglian, Childrenís indigestion tablet, YinLaiTang high dose, YinLaiTang middle dose and YinLaiTang low dose, and these groups had been treated by according drugs to get objectives. Compared with normal group, lung index significantly (p < 0.01) increased in all groups except ribavirin group where lung index obviously (p < 0.05) increased. There was non-significant (p > 0.05) difference in the values of lung homogenate virus titer between dyspepsia group and other groups. Compared to normal group, there was variable degree of inflammatory cell infiltrations in respiratory tract structures in the animals of other groups, and there was a significant (p < 0.01) increase in the level of serum IL-6, IL-10, and TNF-α in infected and dyspepsia group and significant (p < 0.01) decrease in the level of serum IFN-γ was observed. Compared with single clearing stomach method and single clearing lung approach, lung-stomach treatment reduced the level of IL-6 with non-significant difference (p > 0.05) and increased the level of IL-10 obviously, and compared with the single clearing lung method, there was a significant difference (p < 0.05). Compared with the single clearing stomach method and the single clearing lung method, the lung-stomach treatment method had a better efficacy and showed effects on the expression of pro-inflammatory factor and anti-inflammatory factor.
机译:本研究的目的是评估效力,并详细阐述尹莱汤(肺胃治疗)对由FM1病毒感染的消化不良小鼠的作用机制。九十雄,4周龄昆明小鼠患有12-14克的重量,随机分为9组,即正常,感染,消化不良,利巴林,双头莲,儿童消化不良片,银塘高剂量,银塘中剂量和银塔塘低剂量,这些群体被毒品治疗了目标。与正常组相比,肺指数显着(P <0.01),除磷碱组外,肺指数明显增加(P <0.05)。消化不良组和其他组之间的肺匀浆病毒滴度值是非显着的(p> 0.05)差异。与正常组相比,在其他组的动物中存在呼吸道结构中的可变程度的炎症细胞浸润,并且血清IL-6,IL-10和TNF水平增加(P <0.01)增加 - 观察到的血清IFN-γ的血清IFN-γ水平降低,感染和消化不良群和显着(P <0.01)降低。与单一清除胃法相比和单一清除肺方法,肺胃处理降低了IL-6水平,非显着差异(p> 0.05),显然增加了IL-10水平,并与单个清除肺相比方法,有显着差异(P <0.05)。与单次清除胃法和单透明肺法相比,肺胃处理方法具有更好的功效,并对促炎症因子和抗炎因子的表达表现出影响。

著录项

  • 来源
  • 作者单位

    School of Basic Medical Sciences Beijing University of Chinese Medicine Beijing 100029 China;

    School of Basic Medical Sciences Beijing University of Chinese Medicine Beijing 100029 China;

    School of Basic Medical Sciences Beijing University of Chinese Medicine Beijing 100029 China;

    School of Basic Medical Sciences Beijing University of Chinese Medicine Beijing 100029 China;

    School of Basic Medical Sciences Beijing University of Chinese Medicine Beijing 100029 China;

    School of Basic Medical Sciences Beijing University of Chinese Medicine Beijing 100029 China;

    School of Basic Medical Sciences Beijing University of Chinese Medicine Beijing 100029 China;

    Department of Pharmaceutical Sciences COMSATS Institute of Information Technology Abbottabad;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Cytokines; Dyspepsia; FM1 virus; Lung-stomach treatment;

    机译:细胞因子;消化不良;FM1病毒;肺胃治疗;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号